Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Hepatology · Autoimmune Hepatitis Overlap Syndrome

Biology, Diagnosis, and Your Pathology Report

At a Glance

Diagnosing an AIH-PBC or AIH-PSC overlap syndrome requires evaluating both liver cells and bile ducts. Doctors use blood tests, MRI scans, and biopsies to identify specific markers like interface hepatitis, florid duct lesions, and onion-skin fibrosis to confirm this dual immune attack.

Understanding an overlap syndrome requires looking at your liver from two different angles: the health of your liver cells (hepatocytes) and the health of your bile ducts. In an overlap syndrome, your immune system is essentially conducting a dual attack on both [1]. To confirm this, doctors use a combination of blood tests, imaging, and a liver biopsy.

Decoding the Diagnosis

Because overlap syndromes are complex, doctors use specific frameworks to ensure they aren’t missing anything.

AIH-PBC and the “Paris Criteria”

The most common way to diagnose an AIH-PBC overlap is through the Paris Criteria. This framework generally looks for specific markers for each disease [2][3]:

  • For the PBC “Side”: Elevated ALP (alkaline phosphatase), presence of AMA (antimitochondrial antibodies) in the blood, and a biopsy showing “florid duct lesions” (active destruction of bile ducts) [4][5].
  • For the AIH “Side”: High ALT (alanine aminotransferase), high IgG (immunoglobulin G) or positive SMA (smooth muscle antibodies), and a biopsy showing moderate-to-severe “interface hepatitis” [5].

Research shows that patients may not strictly meet every single numerical rule of the Paris Criteria but still benefit from being treated as an overlap case, so doctors look at the complete clinical picture [6][7].

AIH-PSC Diagnosis

Diagnosing an AIH-PSC overlap relies heavily on imaging. Doctors look for the “hepatitis” features mentioned above (high ALT and IgG) combined with an MRCP (a specialized MRI) that shows multiple narrowing strictures of the bile ducts [8][9].

Your Pathology Report Checklist

When you look at your liver biopsy report, several key terms act as “fingerprints” for an overlap syndrome:

  • Interface Hepatitis: This is the hallmark of AIH. It means inflammation is spilling out from the liver’s portal areas into the actual liver tissue [5].
  • Florid Duct Lesions: This is a classic PBC marker. It describes inflammatory cells actively attacking a bile duct [4].
  • Onion-Skin (Periductal) Fibrosis: This is a classic PSC marker. It refers to concentric rings of scar tissue that wrap around the bile ducts like the layers of an onion [10].
  • Ductopenia: This simply means there are fewer bile ducts than there should be, suggesting some have already been destroyed [4].

The “Look-Alike”: Drug-Induced Liver Injury (DILI)

One of the most important jobs for your doctor is to make sure you don’t actually have Drug-Induced Liver Injury (DILI). Certain medications or herbal supplements can cause the immune system to “mimic” an autoimmune overlap [11].

DILI often starts suddenly after a new medication, whereas autoimmune overlap syndromes typically develop slowly over months or years. Your doctor will carefully review your medication history and may look for specific signs on your biopsy, such as a pigment called lipofuscinosis, which strongly points to drug injury rather than an autoimmune disease [12].

Common questions in this guide

What is the Paris Criteria for liver disease?
The Paris Criteria is a medical framework used to diagnose an AIH-PBC overlap syndrome. It requires the presence of specific blood test markers, such as elevated ALP and AMA, along with classic liver biopsy findings like florid duct lesions and interface hepatitis.
What does interface hepatitis mean on my liver biopsy report?
Interface hepatitis is the hallmark sign of autoimmune hepatitis (AIH). It indicates that inflammation is actively spreading from the portal areas of the liver directly into the surrounding liver tissue.
How do doctors diagnose an AIH-PSC overlap syndrome?
Diagnosing AIH-PSC overlap typically requires a specialized MRI called an MRCP. This scan looks for multiple narrowing strictures in the bile ducts, which are evaluated alongside blood tests showing high liver enzymes and antibodies.
What are florid duct lesions?
Florid duct lesions are a classic diagnostic marker for primary biliary cholangitis (PBC). This term describes a pattern seen on a liver biopsy where inflammatory immune cells are actively attacking the bile ducts.
Could my medications or supplements be causing my liver inflammation?
Yes, certain prescription medications and herbal supplements can cause drug-induced liver injury (DILI), which closely mimics autoimmune overlap syndromes. Doctors carefully review your medication history and look for specific biopsy signs to rule this out.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.My report mentions 'interface hepatitis.' Does the severity of this finding influence how aggressively we should start immunosuppressants?
  2. 2.Does my biopsy show 'florid duct lesions' or 'onion-skin fibrosis,' and which specific overlap does that point toward?
  3. 3.I noticed my IgG and ALT levels are elevated. Do these meet the criteria for an overlap syndrome?
  4. 4.If my AMA antibody test was negative, are there other markers or imaging findings that confirm I have PBC or PSC features?
  5. 5.How can we be certain my liver inflammation isn't a reaction to a medication or supplement (DILI) rather than an autoimmune condition?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Autoimmune Hepatitis Overlap Syndromes and Liver Pathology.

    Czaja AJ, Carpenter HA

    Gastroenterology clinics of North America 2017; (46(2)):345-364 doi:10.1016/j.gtc.2017.01.008.

    PMID: 28506369
  2. 2

    The phenotypic landscape of primary biliary cholangitis and autoimmune hepatitis variants.

    Bolis F, Cazzaniga G, Pagni F, et al.

    Gastroenterologia y hepatologia 2025; (48(2)):502225 doi:10.1016/j.gastrohep.2024.502225.

    PMID: 38950647
  3. 3

    Double Trouble: Drug-Induced Autoimmune Hepatitis (AIH)-Primary Biliary Cholangitis (PBC) Overlap Syndrome Triggered by Hydralazine.

    Chaudhuri U, Forrest JR, Sastry K, et al.

    Cureus 2025; (17(5)):e84405 doi:10.7759/cureus.84405.

    PMID: 40535405
  4. 4

    When to Consider AIH-PBC Overlap Syndrome in the Pathology Report.

    Chen W, Xu H, Wegermann K, Chen F

    The American journal of surgical pathology 2026; (50(7)):814-824 doi:10.1097/PAS.0000000000002547.

    PMID: 41989769
  5. 5

    Chronic Liver Disease, Not Everything Is What It Seems: Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome.

    Rodrigues Barbosa B, Pereira L, Campante F, Pona AP

    Cureus 2024; (16(1)):e51630 doi:10.7759/cureus.51630.

    PMID: 38313999
  6. 6

    Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy.

    Stoelinga AEC, Biewenga M, Drenth JPH, et al.

    JHEP reports : innovation in hepatology 2024; (6(7)):101088 doi:10.1016/j.jhepr.2024.101088.

    PMID: 38974367
  7. 7

    Primary Biliary Cholangitis (PBC)-Autoimmune Hepatitis (AIH) Variant Syndrome: Clinical Features, Response to Therapy and Long-Term Outcome.

    Graf M, Lange CM, Langer MM, et al.

    Journal of clinical medicine 2023; (12(22)) doi:10.3390/jcm12227047.

    PMID: 38002661
  8. 8

    Autoimmune Disorders of the Liver and Biliary Tract.

    Anderson CM, Welle CL, Ludwig DR, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(4)):e240126 doi:10.1148/rg.240126.

    PMID: 40111901
  9. 9

    Editorial: Are changes in quantitative biliary metrics the first sign of progression in primary sclerosing cholangitis?

    Eaton JE, Venkatesh SK

    Alimentary pharmacology & therapeutics 2024; (59(12)):1630-1631 doi:10.1111/apt.17996.

    PMID: 38643506
  10. 10

    Overlap syndrome of seronegative primary biliary cholangitis and small duct primary sclerosing cholangitis: a first case report and literature review.

    Souissi S, Laabidi S, Mustpha NB, et al.

    Future science OA 2024; (10(1)):FSO971 doi:10.2144/fsoa-2023-0187.

    PMID: 38817389
  11. 11

    Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.

    de Boer YS, Kosinski AS, Urban TJ, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017; (15(1)):103-112.e2 doi:10.1016/j.cgh.2016.05.043.

    PMID: 27311619
  12. 12

    Lipofuscinosis as a novel discriminating feature for drug-induced liver injury from autoimmune hepatitis.

    Weber S, Erhardt F, Neumann J, et al.

    Scandinavian journal of gastroenterology 2025; 1-7 doi:10.1080/00365521.2025.2517207.

    PMID: 40518721

This page explains autoimmune liver disease pathology terminology for educational purposes. Your hepatologist and pathologist are the best sources for interpreting your specific biopsy results and imaging.

Get notified when new evidence is published on Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.